*ST河化(000953.SZ):2020年實現扭虧為盈 預盈2200萬元–3200萬元
格隆匯 1 月 22日丨*ST河化(000953.SZ)披露2020年度業績預吿,預計2020年度歸屬於上市公司股東的淨利潤2200萬元–3200萬元,上年同期虧損6091.66萬元;歸屬於上市公司股東的扣除非經常性損益後的淨利潤3300萬元–4300萬元,上年同期虧損6371.00萬元;基本每股收益約0.0612元—0.0890元。業績變動原因如下:
1、公司於2019年末完成重大資產重組,置出虧損的尿素生產線資產及部分負債,並收購重慶南松醫藥科技有限公司(“南松醫藥”)控股權,新收購公司2020年度業績納入公司2020年度報吿合併報表範圍,造成公司報吿期合併範圍較上年同期發生較大變動,業績大幅提升。
2、新冠肺炎疫情因素使公司新收購的子公司南松醫藥報吿期內產品需求及產品價格產生較大波動,從而導致其業績大幅波動。
3、因下半年匯率波動,計提匯兑損失約400萬元。
4、報吿期末南松醫藥根據公司重大資產重組相關協議約定,計提業績承諾獎勵1000萬元至1300萬元。此項為非經常性損益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.